HomeAbout UsContact Us1-800-477-6037
Medical Device Daily
Archive Search

User ID


Forgot password

Remember my login

New User ?

Products & Services
Medical Device Daily
Medtech Resources
BioWorld Executive Compensation Report 2014
MDD State of the Industry Report 2013
BioWorld and Medical Device VC Directory 2012
MDD Perspectives
BioWorld Today
Biotech Resources
Perspectives Blog
PMA and 501(k) Approvals

Today's Issue of Medical Device Daily

Saturday, July 4, 2015

Today's Headlines

Investment in Obesity: Ethicon pours $3.2 million into research around 'diabesity' and other metabolic issues

A handful of medical device companies have stepped up lately to address obesity, which wasn't even widely-recognized as a disease until a few years ago. Ethicon (Cincinnati) reported a $3.2 million investment in clinical research to better understand how earlier surgical intervention may improve obesity and Type 2 diabetes.

Hot takes on the heat over HIT

Healthcare IT has generated a lot of press coverage lately, but to hear providers tell it, HIT does not generate enough coverage (or reimbursement) of the Medicare kind. It's fun to speculate that more reimbursement might lead to less media coverage because more jingle should fix the problem, but it hasn't worked out that way to date. (MDD Perspectives)

EuroPCR 2015: Safer, efficient TAVI challenges surgery as gold standard

PARIS — Citing clinical results they qualified as "fabulous," and "impressive," two key opinion leaders affiliated with Edwards Lifesciences (Irvine, California) are calling for an end to the dominance of open-chest surgery as the gold standard for treating patients with stenosis of the aortic valve.

MDD Home   |   About MDD   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement   |   Free Alerts

Part of Thomson Reuters
thomsonreuters.com | lifesciences.thomsonreuters.com | BioWorld.com | medicaldevicedaily.com